Dimensional Fund Advisors LP Reduces Stock Position in Teladoc Health, Inc. (NYSE:TDOC)

Dimensional Fund Advisors LP trimmed its holdings in shares of Teladoc Health, Inc. (NYSE:TDOC) by 22.0% in the 2nd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 3,795,287 shares of the health services provider’s stock after selling 1,069,540 shares during the quarter. Dimensional Fund Advisors LP owned 2.22% of Teladoc Health worth $37,122,000 at the end of the most recent reporting period.

A number of other large investors have also recently made changes to their positions in TDOC. Norges Bank bought a new position in shares of Teladoc Health in the 4th quarter worth $9,714,000. Parallel Advisors LLC raised its holdings in Teladoc Health by 14.6% in the fourth quarter. Parallel Advisors LLC now owns 4,038 shares of the health services provider’s stock worth $87,000 after purchasing an additional 515 shares in the last quarter. Allianz Asset Management GmbH raised its holdings in Teladoc Health by 15.4% in the fourth quarter. Allianz Asset Management GmbH now owns 604,238 shares of the health services provider’s stock worth $13,021,000 after purchasing an additional 80,805 shares in the last quarter. Treasurer of the State of North Carolina lifted its position in shares of Teladoc Health by 2.2% during the fourth quarter. Treasurer of the State of North Carolina now owns 73,127 shares of the health services provider’s stock valued at $1,576,000 after buying an additional 1,570 shares during the last quarter. Finally, Pinebridge Investments L.P. boosted its holdings in shares of Teladoc Health by 83.2% in the 4th quarter. Pinebridge Investments L.P. now owns 55,428 shares of the health services provider’s stock valued at $1,194,000 after buying an additional 25,171 shares in the last quarter. 76.82% of the stock is owned by hedge funds and other institutional investors.

Teladoc Health Trading Up 8.5 %

Shares of TDOC stock opened at $9.18 on Tuesday. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.66 and a quick ratio of 1.62. Teladoc Health, Inc. has a twelve month low of $6.76 and a twelve month high of $22.54. The company’s 50-day moving average price is $7.93 and its 200-day moving average price is $10.58.

Teladoc Health (NYSE:TDOC) last posted its earnings results on Wednesday, July 31st. The health services provider reported ($0.28) earnings per share for the quarter, beating the consensus estimate of ($0.36) by $0.08. The company had revenue of $642.44 million for the quarter, compared to analyst estimates of $649.34 million. Teladoc Health had a negative net margin of 38.54% and a negative return on equity of 10.25%. As a group, equities analysts expect that Teladoc Health, Inc. will post -1.18 earnings per share for the current year.

Analysts Set New Price Targets

Several brokerages have weighed in on TDOC. Deutsche Bank Aktiengesellschaft lowered their target price on shares of Teladoc Health from $15.00 to $10.00 and set a “hold” rating for the company in a research note on Friday, August 2nd. TD Cowen reduced their target price on Teladoc Health from $15.00 to $9.00 and set a “hold” rating on the stock in a research report on Thursday, August 1st. Cantor Fitzgerald reissued an “overweight” rating and issued a $10.00 price target on shares of Teladoc Health in a report on Tuesday, August 20th. Canaccord Genuity Group cut their price objective on shares of Teladoc Health from $25.00 to $17.00 and set a “buy” rating on the stock in a report on Thursday, August 1st. Finally, Evercore ISI dropped their target price on shares of Teladoc Health from $14.00 to $10.00 and set an “in-line” rating on the stock in a research report on Tuesday, July 9th. Fifteen investment analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to MarketBeat, the company has a consensus rating of “Hold” and a consensus target price of $12.31.

Insider Activity at Teladoc Health

In other news, Director Thomas Mckinley acquired 4,000 shares of the business’s stock in a transaction that occurred on Thursday, September 12th. The shares were purchased at an average price of $7.69 per share, for a total transaction of $30,760.00. Following the acquisition, the director now owns 39,077 shares of the company’s stock, valued at $300,502.13. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. In other Teladoc Health news, Director Thomas Mckinley acquired 4,000 shares of the stock in a transaction dated Thursday, September 12th. The stock was acquired at an average price of $7.69 per share, with a total value of $30,760.00. Following the completion of the purchase, the director now owns 39,077 shares in the company, valued at approximately $300,502.13. The purchase was disclosed in a document filed with the SEC, which is available through this hyperlink. Also, CEO Laizer Kornwasser sold 10,879 shares of the business’s stock in a transaction on Friday, August 2nd. The stock was sold at an average price of $8.14, for a total transaction of $88,555.06. Following the completion of the transaction, the chief executive officer now owns 99,929 shares of the company’s stock, valued at approximately $813,422.06. The disclosure for this sale can be found here. In the last quarter, insiders sold 57,377 shares of company stock worth $438,054. Insiders own 0.95% of the company’s stock.

Teladoc Health Company Profile

Teladoc Health, Inc provides virtual healthcare services worldwide. The company operates through Teladoc Health Integrated Care and BetterHelp segments. The Integrated Care segment offers virtual medical services, including general medical, expert medical, specialty medical, chronic condition management, and mental health, as well as enabling technologies and enterprise telehealth solutions for hospitals and health systems.